FDA recall record

Otis McAllister Product LAbeled in part: "Emerald River Premium Thai Jasmine recall — FDA F-1108-2024

Foreign object; piece of glass.

Class IIclassification
F-1108-2024official record ID
Apr 3, 2024report date

Recall record at a glance

Official recordF-1108-2024
CategoryFood Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmOtis McAllister
Report dateApr 3, 2024
Recall initiation dateMar 6, 2024
Quantity2700 bags
LocationOrinda, CA, United States

Official product description

Product LAbeled in part: "Emerald River Premium Thai Jasmine Rice ... Net Wt 50 lb (22.7 kg) ... UPC 0 28571 00474 6"

Why the product was recalled

Foreign object; piece of glass.

Distribution information

U.S. distribution to the following: UT, OR, TX, WA No foreign distribution.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.